CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Lazard Capital Markets 7th Annual Healthcare Conference on Wednesday, November 17 at 1:45 p.m. ET at The St. Regis in New York City.
